| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adenosine hypothesis of schizophrenia – Opportunities for pharmacotherapy
|
Boison, Detlev
|
|
2012
|
62 |
3 |
p. 1527-1543
17 p.
|
artikel
|
| 2 |
Alterations in hippocampal excitability, synaptic transmission and synaptic plasticity in a neurodevelopmental model of schizophrenia
|
Sanderson, Thomas M.
|
|
2012
|
62 |
3 |
p. 1349-1358
10 p.
|
artikel
|
| 3 |
Asenapine effects on cognitive and monoamine dysfunction elicited by subchronic phencyclidine administration
|
Elsworth, John D.
|
|
2012
|
62 |
3 |
p. 1442-1452
11 p.
|
artikel
|
| 4 |
Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia
|
Powell, Susan B.
|
|
2012
|
62 |
3 |
p. 1322-1331
10 p.
|
artikel
|
| 5 |
Cholinergic contributions to the cognitive symptoms of schizophrenia and the viability of cholinergic treatments
|
Sarter, Martin
|
|
2012
|
62 |
3 |
p. 1544-1553
10 p.
|
artikel
|
| 6 |
Chronic phencyclidine (PCP)-induced modulation of muscarinic receptor mRNAs in rat brain : Impact of antipsychotic drug treatment
|
Steward, Lucinda J.
|
|
2012
|
62 |
3 |
p. 1554-1563
10 p.
|
artikel
|
| 7 |
Contributions of the d-serine pathway to schizophrenia
|
Labrie, Viviane
|
|
2012
|
62 |
3 |
p. 1484-1503
20 p.
|
artikel
|
| 8 |
Differential effects of NMDA antagonists on high frequency and gamma EEG oscillations in a neurodevelopmental model of schizophrenia
|
Phillips, K.G.
|
|
2012
|
62 |
3 |
p. 1359-1370
12 p.
|
artikel
|
| 9 |
Differential effects of the mGluR5 positive allosteric modulator CDPPB in the cortex and striatum following repeated administration
|
Parmentier-Batteur, Sophie
|
|
2012
|
62 |
3 |
p. 1453-1460
8 p.
|
artikel
|
| 10 |
DISC1-binding proteins in neural development, signalling and schizophrenia
|
Bradshaw, Nicholas J.
|
|
2012
|
62 |
3 |
p. 1230-1241
12 p.
|
artikel
|
| 11 |
Do GluA1 knockout mice exhibit behavioral abnormalities relevant to the negative or cognitive symptoms of schizophrenia and schizoaffective disorder?
|
Barkus, Chris
|
|
2012
|
62 |
3 |
p. 1263-1272
10 p.
|
artikel
|
| 12 |
Dopamine system dysregulation by the hippocampus: Implications for the pathophysiology and treatment of schizophrenia
|
Grace, Anthony A.
|
|
2012
|
62 |
3 |
p. 1342-1348
7 p.
|
artikel
|
| 13 |
Editorial board
|
|
|
2012
|
62 |
3 |
p. IFC-
1 p.
|
artikel
|
| 14 |
Extracellular matrix abnormalities in schizophrenia
|
Berretta, Sabina
|
|
2012
|
62 |
3 |
p. 1584-1597
14 p.
|
artikel
|
| 15 |
GABAergic interneuron origin of schizophrenia pathophysiology
|
Nakazawa, Kazu
|
|
2012
|
62 |
3 |
p. 1574-1583
10 p.
|
artikel
|
| 16 |
Gamma synchrony: Towards a translational biomarker for the treatment-resistant symptoms of schizophrenia
|
Gandal, Michael J.
|
|
2012
|
62 |
3 |
p. 1504-1518
15 p.
|
artikel
|
| 17 |
Gene-dose dependent effects of methamphetamine on interval timing in dopamine-transporter knockout mice
|
Meck, Warren H.
|
|
2012
|
62 |
3 |
p. 1221-1229
9 p.
|
artikel
|
| 18 |
Genetic mouse models relevant to schizophrenia: Taking stock and looking forward
|
Harrison, Paul J.
|
|
2012
|
62 |
3 |
p. 1164-1167
4 p.
|
artikel
|
| 19 |
Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia
|
Fell, Matthew J.
|
|
2012
|
62 |
3 |
p. 1473-1483
11 p.
|
artikel
|
| 20 |
Intermittent treatment with olanzapine causes sensitization of the metabolic side-effects in rats
|
Boyda, H.N.
|
|
2012
|
62 |
3 |
p. 1391-1400
10 p.
|
artikel
|
| 21 |
Lamina- and cell-specific alterations in cortical somatostatin receptor 2 mRNA expression in schizophrenia
|
Beneyto, Monica
|
|
2012
|
62 |
3 |
p. 1598-1605
8 p.
|
artikel
|
| 22 |
Metabotropic glutamate receptors as therapeutic targets for schizophrenia
|
Vinson, Paige N.
|
|
2012
|
62 |
3 |
p. 1461-1472
12 p.
|
artikel
|
| 23 |
Mouse models of genetic effects on cognition: Relevance to schizophrenia
|
Papaleo, Francesco
|
|
2012
|
62 |
3 |
p. 1204-1220
17 p.
|
artikel
|
| 24 |
Mouse pharmacological models of cognitive disruption relevant to schizophrenia
|
Young, Jared W.
|
|
2012
|
62 |
3 |
p. 1381-1390
10 p.
|
artikel
|
| 25 |
Mutant DISC1 affects methamphetamine-induced sensitization and conditioned place preference: a comorbidity model
|
Pogorelov, Vladimir M.
|
|
2012
|
62 |
3 |
p. 1242-1251
10 p.
|
artikel
|
| 26 |
Neurobehavioral and metabolic long-term consequences of neonatal maternal deprivation stress and adolescent olanzapine treatment in male and female rats
|
Llorente-Berzal, Alvaro
|
|
2012
|
62 |
3 |
p. 1332-1341
10 p.
|
artikel
|
| 27 |
New translational assays for preclinical modelling of cognition in schizophrenia: The touchscreen testing method for mice and rats
|
Bussey, T.J.
|
|
2012
|
62 |
3 |
p. 1191-1203
13 p.
|
artikel
|
| 28 |
NMDA receptors, cognition and schizophrenia – Testing the validity of the NMDA receptor hypofunction hypothesis
|
Gilmour, Gary
|
|
2012
|
62 |
3 |
p. 1401-1412
12 p.
|
artikel
|
| 29 |
Prenatal exposure to a viral mimetic alters behavioural flexibility in male, but not female, rats
|
Zhang, Ying
|
|
2012
|
62 |
3 |
p. 1299-1307
9 p.
|
artikel
|
| 30 |
Psychopharmacological treatment of schizophrenia: What do we have, and what could we get?
|
Ellenbroek, Bart A.
|
|
2012
|
62 |
3 |
p. 1371-1380
10 p.
|
artikel
|
| 31 |
Rats tested after a washout period from sub-chronic PCP administration exhibited impaired performance in the 5-Choice Continuous Performance Test (5C-CPT) when the attentional load was increased
|
Barnes, Sam A.
|
|
2012
|
62 |
3 |
p. 1432-1441
10 p.
|
artikel
|
| 32 |
Repeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of rats
|
Amitai, Nurith
|
|
2012
|
62 |
3 |
p. 1422-1431
10 p.
|
artikel
|
| 33 |
Reversal learning and attentional set-shifting in mice
|
Bissonette, Gregory B.
|
|
2012
|
62 |
3 |
p. 1168-1174
7 p.
|
artikel
|
| 34 |
Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits
|
D’Souza, Manoranjan S.
|
|
2012
|
62 |
3 |
p. 1564-1573
10 p.
|
artikel
|
| 35 |
Selective phosphodiesterase inhibitors improve performance on the ED/ID cognitive task in rats
|
Rodefer, Joshua S.
|
|
2012
|
62 |
3 |
p. 1182-1190
9 p.
|
artikel
|
| 36 |
Synergistic interactions between PDE4B and GSK-3: DISC1 mutant mice
|
Lipina, Tatiana V.
|
|
2012
|
62 |
3 |
p. 1252-1262
11 p.
|
artikel
|
| 37 |
The role of neurexins in schizophrenia and autistic spectrum disorder
|
Reichelt, A.C.
|
|
2012
|
62 |
3 |
p. 1519-1526
8 p.
|
artikel
|
| 38 |
The viral theory of schizophrenia revisited: Abnormal placental gene expression and structural changes with lack of evidence for H1N1 viral presence in placentae of infected mice or brains of exposed offspring
|
Fatemi, S. Hossein
|
|
2012
|
62 |
3 |
p. 1290-1298
9 p.
|
artikel
|
| 39 |
Timing as a window on cognition in schizophrenia
|
Ward, Ryan D.
|
|
2012
|
62 |
3 |
p. 1175-1181
7 p.
|
artikel
|
| 40 |
To poly(I:C) or not to poly(I:C): Advancing preclinical schizophrenia research through the use of prenatal immune activation models
|
Meyer, Urs
|
|
2012
|
62 |
3 |
p. 1308-1321
14 p.
|
artikel
|
| 41 |
Tracing the development of psychosis and its prevention: What can be learned from animal models
|
Piontkewitz, Yael
|
|
2012
|
62 |
3 |
p. 1273-1289
17 p.
|
artikel
|
| 42 |
Translational Models of Schizophrenia
|
Lodge, David
|
|
2012
|
62 |
3 |
p. 1163-
1 p.
|
artikel
|
| 43 |
T-type calcium channel antagonism produces antipsychotic-like effects and reduces stimulant-induced glutamate release in the nucleus accumbens of rats
|
Uslaner, Jason M.
|
|
2012
|
62 |
3 |
p. 1413-1421
9 p.
|
artikel
|
Tijdschrift beschrijving